1283031056967491586

Our investigational cell therapy, omidubicel, has the potential to expand access to #bonemarrowtransplants for patients who are unable to find matches using current graft sources, including underserved patient populations. Learn more about omidubicel here: https://t.co/bsQNQuwGSX

Send us a message